These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1186296

  • 1. Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota.
    Donnelly PK, Baker KW, Carney JA, O'Fallon WM.
    Mayo Clin Proc; 1975 Nov; 50(11):650-6. PubMed ID: 1186296
    [Abstract] [Full Text] [Related]

  • 2. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer incidence, prevalence, mortality, and survivorship in Rochester, Minnesota, 1935 to 1974.
    Brian DD, Melton LJ, Goellner JR, Williams RL, O'Fallon WM.
    Mayo Clin Proc; 1980 Jun 15; 55(6):355-9. PubMed ID: 7382542
    [Abstract] [Full Text] [Related]

  • 4. [Study of the importance of fibrocystic mastopathy as a precancerous lesion].
    Napolitano A, Di Curzio B, Stella S.
    Ann Ital Chir; 1980 Jun 15; 48(3-4):265-76. PubMed ID: 4378000
    [No Abstract] [Full Text] [Related]

  • 5. Follow-up recommendations for benign breast biopsies.
    Shin S, Schneider HB, Cole FJ, Laronga C.
    Breast J; 2006 Jun 15; 12(5):413-7. PubMed ID: 16958957
    [Abstract] [Full Text] [Related]

  • 6. [Relation between dysplasias, benign breast tumors and cancer of the breast. Retrospective study in a group of 735 patients].
    Badellino F, Santoro L, Volterrani P, Trabucco A, Tardy A.
    Cancro; 1974 Jun 15; 27(5):263-70. PubMed ID: 4376974
    [No Abstract] [Full Text] [Related]

  • 7. [Morphologically detectable prestages of breast cancer].
    Prechtel K, Gehm O.
    Osterr Z Onkol; 1975 Jun 15; 2(5):122-5. PubMed ID: 1243827
    [Abstract] [Full Text] [Related]

  • 8. Risk of breast cancer in women with benign breast disease.
    Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B.
    J Natl Cancer Inst; 1980 Jul 15; 65(1):13-20. PubMed ID: 6930509
    [Abstract] [Full Text] [Related]

  • 9. Benign breast disease and the risk of breast cancer.
    Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ, Visscher DW.
    N Engl J Med; 2005 Jul 21; 353(3):229-37. PubMed ID: 16034008
    [Abstract] [Full Text] [Related]

  • 10. The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases.
    Ciatto S, Andreoli C, Cirillo A, Bonardi R, Bianchi S, Santoro G, Farante G, Magni A, Campa T, Costa A.
    Tumori; 1991 Feb 28; 77(1):41-3. PubMed ID: 2017798
    [Abstract] [Full Text] [Related]

  • 11. [Fibro-cystic mastosis and cancer (206 cases of mastosis in possible relation with 12 cases of cancer)].
    Chardot C, Varroy A, Parache RM.
    Bull Cancer; 1970 Feb 28; 57(2):251-68. PubMed ID: 5505161
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer risk in women with radial scars in benign breast biopsies.
    Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC.
    Breast Cancer Res Treat; 2008 Mar 28; 108(2):167-74. PubMed ID: 18297395
    [Abstract] [Full Text] [Related]

  • 13. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases.
    Thomas DB, Persing JP, Hutchinson WB.
    J Natl Cancer Inst; 1982 Nov 28; 69(5):1017-25. PubMed ID: 6957648
    [Abstract] [Full Text] [Related]

  • 14. [Study on follow-up of patients with biopsy-proven breast disease].
    Kojima O, Takahashi T, Hagiwara A, Horie H, Matsui M, Tamura Y, Takemoto Y.
    Nihon Geka Gakkai Zasshi; 1989 Sep 28; 90(9):1399-402. PubMed ID: 2586427
    [Abstract] [Full Text] [Related]

  • 15. Relation between component parts of fibrocystic disease complex and breast cancer.
    Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH.
    J Natl Cancer Inst; 1978 Oct 28; 61(4):1055-63. PubMed ID: 279711
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions: evidence against a precursor role.
    Boulos FI, Dupont WD, Schuyler PA, Sanders ME, Page DL, Fedda FA, Simpson JF.
    Cancer; 2012 May 01; 118(9):2372-7. PubMed ID: 21918964
    [Abstract] [Full Text] [Related]

  • 17. [Which benign breast disorders form a risk factor for breast carcinoma ?].
    Giard RW.
    Ned Tijdschr Geneeskd; 1987 Oct 03; 131(40):1752-4. PubMed ID: 3670479
    [No Abstract] [Full Text] [Related]

  • 18. Pathologic considerations in the high-risk breast patient.
    Simmons R, Serafin D, McCarty K.
    Clin Plast Surg; 1988 Oct 03; 15(4):655-65. PubMed ID: 2852084
    [Abstract] [Full Text] [Related]

  • 19. Use of risk factors in counseling patients.
    Love SM.
    Hematol Oncol Clin North Am; 1989 Dec 03; 3(4):599-610. PubMed ID: 2691491
    [Abstract] [Full Text] [Related]

  • 20. Clinical benign disorders of the breast and carcinoma of the breast.
    Devitt JE.
    Surg Gynecol Obstet; 1981 Apr 03; 152(4):437-40. PubMed ID: 7209771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.